Diabetes is on the rise in children and young people

Published Date: 10 Mar 2023

New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...

Read Full News

Latest News

FDA Accepts for Priority Review sBLA for Teplizumab for Children With Stage 2 T1D

FDA Accepts for Priority Review sBLA for Teplizumab for Children With Stage 2 T1D

HCPLive 5 Stories in Under 5: Week of 12/28

HCPLive 5 Stories in Under 5: Week of 12/28

Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D

Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D

10 FDA Headlines You Missed in December 2025

10 FDA Headlines You Missed in December 2025

Endocrinology in 2025: Year in Review

Endocrinology in 2025: Year in Review

FDA Issues Complete Response Letter for Relacorilant for Hypercortisolism

FDA Issues Complete Response Letter for Relacorilant for Hypercortisolism

Todays Updates

Claims Study Highlights Persistence and Reasons for Fenfluramine Use in Lennox-Gastaut Syndrome Marco Meglio

An AES study revealed the real-world persistence of fenfluramine in treating Lennox-Gastaut syndrome, highlighting patient demographics and treatment trends.

Fenfluramine’s Safety Profile Consistent in Long-Term Extension Dravet and Lennox-Gastaut Syndrome Studies Isabella Ciccone, MPH

Final safety data from an open-label study presented at AES 2025 supported long-term fenfluramine use in pediatric and adult patients with Dravet syndrome or Lennox-Gastaut syndrome.

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Todays Updates

Claims Study Highlights Persistence and Reasons for Fenfluramine Use in Lennox-Gastaut Syndrome Marco Meglio

An AES study revealed the real-world persistence of fenfluramine in treating Lennox-Gastaut syndrome, highlighting patient demographics and treatment trends.

Fenfluramine’s Safety Profile Consistent in Long-Term Extension Dravet and Lennox-Gastaut Syndrome Studies Isabella Ciccone, MPH

Final safety data from an open-label study presented at AES 2025 supported long-term fenfluramine use in pediatric and adult patients with Dravet syndrome or Lennox-Gastaut syndrome.

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Latest News

FDA Accepts for Priority Review sBLA for Teplizumab for Children With Stage 2 T1D

HCPLive 5 Stories in Under 5: Week of 12/28

Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D

10 FDA Headlines You Missed in December 2025

Endocrinology in 2025: Year in Review

FDA Issues Complete Response Letter for Relacorilant for Hypercortisolism

News All Time

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management

How painkillers can contribute to anemia in cancer patients

Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer ...

Evidence builds for disrupted mitochondria as cause of Parkinson's

For decades, scientists have known that mitochondria, which produce energy inside our cells, malfunction in Parkinson's disease. But a critical question remained: do the failing mitochondria cause Parkinson's, or do they ...

Some women start menopause after surgery or medical treatment: Here's how it's different

For most women, menopause occurs naturally around the age of 49. In the lead up to menopause, the quality and quantity of eggs declines over time. Then the ovaries stop releasing eggs completely.

Keto diet associated with reduced depressive symptoms, anxiety results remain mixed

Researchers led by St Michael's Hospital in Toronto report that ketogenic diets are associated with modest reductions in depressive symptoms in adults, while evidence for anxiety remains uncertain.

Study reveals how uterine contractions are regulated by stretch and pressure during childbirth

When labor begins, the uterus must coordinate rhythmic, well-timed contractions to deliver the baby safely. While hormones such as progesterone and oxytocin are key contributors to that process, scientists have long suspected ...

Can't take hormone therapy for menopause? There are other options

Shilpa Gajarawala struggled with hot flashes, night sweats, sleep problems and brain fog. But given her history of breast cancer, treating these menopausal symptoms with hormone therapy wasn't an option.

FDA lifts major warnings on hormone replacement therapy

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

Gut bacterium could be key to tackling obesity crisis

The internet, libraries and bookshops are full of plans and advice on how to lose weight, from fad diets to intense exercise routines. But there could be another route to keeping the pounds away, and that's with a gut bacterium ...

Circadian rhythm discovery may transform what time of day doctors induce labor

In a discovery that could shift labor and delivery practices around the world, researchers at Michigan State University have found that the effectiveness of oxytocin—a common medication used to induce or speed up labor—depends ...

Revised clinical practice guideline for treatment of chronic hypoparathyroidism in adults released

The European Society of Endocrinology (ESE) has published a Revised Clinical Practice Guideline for the Treatment of Chronic Hypoparathyroidism in Adults in the European Journal of Endocrinology.

Vagus nerve's right branch plays a key role in digestive signaling

After years of work, cognition and neuroscience doctoral student Hailey Welch is—for the first time—the lead author of a study published in an academic journal, a paper appearing in Cell Reports, which examined the role ...

Could exercising while losing weight preserve your muscles and help keep them 'young'?

When we lose weight, we don't just lose body fat—we lose muscle, too.

Experimental drug protects mitochondria and prevents kidney injury in mice

Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ranging from sepsis to ...

Recommended News For You

Research identifies nearly 200 potential breast carcinogens in food packaging materials

For incarcerated people, study shows gaps exist in quality of cancer care

Finding a clue to the origin of treatment-resistant leukemia in kids

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

Recommended Articles For You

Polyposis Syndrome: Causes, Symptoms, and Treatment Options 

Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction 

How Cancer Cells Evade Immune Destruction and the Fight Back 

The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Glioblastoma treatment breakthrough shows promise

2.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

3.

Study suggests exercise could reduce breast cancer recurrence

4.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

5.

Daily physical activity, even at light intensities, linked to lower cancer risk

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies

3.

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia

4.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

5.

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot